Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing dichloralphenazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
1 |
Dichloralphenazone poisoning |
Causative agent (attribute) |
True |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
1 |
Accidental dichloralphenazone poisoning (disorder) |
Causative agent (attribute) |
False |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
|
Intentional dichloralphenazone poisoning |
Causative agent (attribute) |
False |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
|
Dichloralphenazone poisoning of undetermined intent |
Causative agent (attribute) |
False |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
1 |
Dichloralphenazone adverse reaction |
Causative agent (attribute) |
True |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
1 |
Allergy to dichloralphenazone |
Causative agent (attribute) |
False |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
|
Dichloralphenazone overdose |
Causative agent (attribute) |
True |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
1 |
Accidental dichloralphenazone overdose |
Causative agent (attribute) |
True |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
1 |
Intentional dichloralphenazone overdose |
Causative agent (attribute) |
True |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
1 |
Dichloralphenazone overdose of undetermined intent |
Causative agent (attribute) |
False |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
|
Product containing dichloralphenazone and isometheptene and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
1 |
Acetaminophen + dichloralantipyrine + isometheptene mucate (1:1) 325mg/100mg/65mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
|
Acetaminophen + dichloralantipyrine + isometheptene mucate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
|
Accidental dichloralphenazone poisoning (disorder) |
Causative agent (attribute) |
True |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
1 |
Intentional dichloralphenazone poisoning |
Causative agent (attribute) |
True |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
1 |
Allergy to dichloralphenazone |
Causative agent (attribute) |
True |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
3 |
Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
3 |
Product containing dichloralphenazone and isometheptene and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
1 |
Product containing only dichloralphenazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
1 |
Product containing only dichloralphenazone and isometheptene and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
1 |
Dichloralphenazone and isometheptene and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dichloralphenazone (substance) |
Inferred relationship |
Some |
1 |